Brien Miller, DO
Gastroenterology · St George, UTNPI 1992066799
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 32.1% of the total. 2025 is the largest year on record at $1,219, 2.3 times the $529 reported in 2019.
Across 279 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$626
- Takeda Pharmaceuticals U.S.A., Inc.$431
- Boston Scientific$378
- Sanofi$280
- Pfizer$186
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,63896%
- Education$1884%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $1,549 |
| Johnson & Johnson | 37 | $626 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $431 |
| Boston Scientific | 15 | $378 |
| Sanofi | 14 | $280 |
| Pfizer | 14 | $186 |
| QOL Medical, LLC | 9 | $148 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $135 |
| Bristol Myers Squibb | 7 | $122 |
| Enterra Medical, Inc. | 1 | $116 |
| Intercept Pharmaceuticals, Inc. | 6 | $102 |
| Braintree Laboratories, Inc. | 6 | $101 |
| Gilead | 5 | $93 |
| Lucid Diagnostics Inc. | 4 | $79 |
| Ipsen Biopharmaceuticals, Inc | 3 | $69 |
| Madrigal Pharmaceuticals | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Orphalan Inc | 2 | $47 |
| Nestle Healthcare Nutrition Inc. | 2 | $41 |
| Novo Nordisk | 2 | $32 |
| Alfasigma USA, Inc. | 1 | $23 |
| Amgen | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Medtronic | 1 | $18 |
| Mylan Institutional Inc. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $11 |
| Ambu Inc. | 1 | $9 |
How this compares
$4,826 in reported general payments places this provider in the 70th percentile of 122 gastroenterology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 84 | $5,901 |
| Mesalamine | 15 | $3,252 |
| Omeprazole | 195 | $2,371 |
| Pantoprazole Sodium | 153 | $2,232 |
| Mesalamine ErMesalamine | 14 | $1,666 |
| Ursodiol | 18 | $1,196 |
| Azathioprine | 18 | $535 |
| Fluconazole | 11 | $164 |
| Spironolactone | 20 | $107 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in St George
- John Erikson YapSt George$94K
- George JeungSt George$5K
- James BownSt George$4K
- Phillip ObergSt George$4K
- Christoph WoerleinSt George$2K
- Scott DiamondSt George$2K
- Terry BoxSalt Lake City$302K
- Richard GilroySalt Lake City$192K
- Kyle EliasonOgden$128K
- Umaprasanna KarnamRiverton$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.